The elevated activity of cysteine cathepsins appears to be a common event in PNET progression, as it has been observed in both the currently presented MycERTAM;Bcl-xL model and previously in the RT2 model [30]. The gene discussed is BCL2L1; the disease is primitive neuroectodermal tumor.